2-(1H-INDOL-3-YL)-2-OXO-ACETAMIDES WITH ANTITUMOR ACTIVITY
申请人:Novuspharma S.p.A.
公开号:EP1244652A1
公开(公告)日:2002-10-02
2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY
申请人:Novuspharma S.p.A.
公开号:EP1322646A1
公开(公告)日:2003-07-02
[EN] 2-(1H-INDOL-3-YL)-2-OXO-ACETAMIDES WITH ANTITUMOR ACTIVITY<br/>[FR] ANTITUMORAUX A BASE DE 2-(1H-INDOL-3-YL)-2-OXO-ACETAMIDES
申请人:NOVUSPHARMA SPA
公开号:WO2001047916A1
公开(公告)日:2001-07-05
2-(1H-Indol-3-yl)-2-oxo-acetamides having antitumor activity, in particular against solid tumors, more precisely colon and lung tumors, of the following formula (I) wherein Y is an oxygen of sulfur atom and X, R1, R2, R3, R4 and R5 are as defined in claim 1.
[EN] 2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY<br/>[FR] AMIDES D'ACIDE ACETIQUE 2-(1H-INDOL-3-YL)-2-OXO A ACTIVITE ANTITUMORALE
申请人:NOVUSPHARMA SPA
公开号:WO2002008225A1
公开(公告)日:2002-01-31
2-(1H-Indol-3-yl)-2-oxo-acetamide derivatives of formula (I) having antitumor activity in particular against solid tumors, specifically colon and lung tumors.
Highly enantioselective hydrogenation of N-unprotected indoles using (S)-C10–BridgePHOS as the chiral ligand
applied to a highly efficient Pd-catalyzed enantioselectivehydrogenation of substituted indoles. The methodology was suitable for the hydrogenation of indoles substituted at the 2-, 3- and 2,3-positions. Products were obtained in quantitative conversion and up to 98% ee. The role the 2-position substituent plays in the hydrogenation process has been proposed. The methodology could be used as an alternative